What is Neurocrine Biosciences's gain (loss) on disposal of assets?

Neurocrine Biosciences (NBIX) reported gain (loss) on disposal of assets of $28.60M in Q1 2026.

What does gain (loss) on disposal of assets mean?

The net profit or loss generated from selling company assets or business segments.

This decline may warrant attention — for this metric, higher values are generally preferred.

StatementIncome Statement

SectionOther Income & Expense

CategoryCapital Allocation

SignalHigher is better

VolatilityVolatile

First reportedQ1 2013

Last reportedQ1 2026May 5, 2026

A gain indicates successful capital recycling or asset appreciation, while a loss may suggest impairment or forced liquidation of assets.

This metric represents the net profit or loss realized from the divestiture of non-core business units, property, equipm...

Standard across all industries; peers often report this within 'Other Income' or 'Non-Operating Items'.

Metric ID: gain_loss_on_sale_of_assets

2 periods

	Q1 '25	Q1 '26
Value	$0.00	$28.60M

Range$0.00 – $28.60M

What is Neurocrine Biosciences's gain (loss) on disposal of assets?: Neurocrine Biosciences (NBIX) reported gain (loss) on disposal of assets of $28.60M in Q1 2026.
What does gain (loss) on disposal of assets mean?: The net profit or loss generated from selling company assets or business segments.